Implementation of new malaria recommendations is a matter of life and death in Africa, where malaria kills between 1 and 2 million people each year.

Through its Campaign for Access to Essential Medicines, MSF has been closely following the developments in the world of access to medicines, vaccines and diagnostics.

Severe malaria has traditionally been treated with quinine. Today, the latest scientific evidence clearly shows that many more children’s lives can be saved by switching treatment from quinine to a more effective drug, artesunate.

Through its Access Campaign, MSF has been closely following the developments in the world of access to medicines, vaccines, and diagnostics.